| |
|
|
|
Adma Biologics  
|
|
2.38 0.14 (0.06%) |
01-20 16:00 |
|
Open: |
2.3 |
Pre close: |
2.24 |
Target:
|
2.88 
|
|
High: |
2.47 |
Low: |
2.29 |
Resistance:
|
2.47
2.88
|
|
Volume: |
6,923,832 |
Market Cap: |
225M |
Support:
|
2.13
1.92
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
2.17
|
MACD |
MACD(12,26):
|
0.04 |
|
MA(20): |
2.13 |
Signal(12,26,9): |
0.02 |
|
MA(100): |
2.16  |
Stochastic Oscillator |
%K(14,3):
|
66.62 |
|
MA(250): |
2.67 |
%D(3): |
58.70 |
|
Average Volume(K) |
3-Month: |
322437
|
52-Week |
High:
|
4.59 |
|
10-Days: |
427192 |
Low: |
1.45 |
|
RSI |
RSI(14):
|
64.31 |
Change(%): |
-47.6 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.871 |
Return on Equity (ttm) |
-124.5 |
Shares Out. (M) |
94.55 |
|
EPS Est. Current Year |
-1.740 |
Return on Assets (ttm) |
-21.2 |
Shares Float (M) |
76.07 |
|
EPS Est. Next Year |
-1.080 |
PEG Ratio |
0.00 |
% Held by Insiders |
2.13 |
|
EPS Est. Next Quarter |
-0.370 |
Qtrly Rev. Growth |
42.3 |
% Held by Institutions |
54.51 |
|
Forward EPS |
-0.890 |
Gross Profit (p.s.) |
-0.107 |
Shares Short (K) |
11970 |
|
Book Value (p.s.) |
0.800 |
EBITDA (p.s.) |
-0.550 |
P/E |
-2.73 |
|
Sales Per Share |
0.426 |
Qtrly Earnings Growth |
0.00 |
P/BV |
2.98 |
|
Profit Margin |
-166.01 |
Operating Cash Flow
(M) |
-89.44 |
P/S |
5.58 |
|
Operating Margin |
-137.77 |
Levered Free Cash Flow
(M) |
-73.81 |
P/CF |
-2.52 |
|
|
|
|
|
|
